Legal Representation
Attorney
Barbara J. Grahn
USPTO Deadlines
Application History
40 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 27, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jul 27, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Jan 7, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 2, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 2, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Dec 20, 2019 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Dec 20, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 20, 2019 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jun 22, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 20, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 20, 2019 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jun 20, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Dec 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 19, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 19, 2018 | EXT3 | S | SOU EXTENSION 3 FILED |
| Dec 19, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jun 14, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 12, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 12, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 12, 2018 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 12, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Dec 9, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 7, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 7, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 7, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 21, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 25, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 25, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 5, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 11, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 8, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 8, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 8, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 20, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 20, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 20, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Dec 13, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 10, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 9, 2016 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 036
Consulting, administration, and implementation services that help organizations develop and manage their health insurance benefits and programs, namely, health insurance consultation, health insurance administration, and processing, administering, and managing employee benefit plans concerning health insurance; Administration, financial management, and maintenance of tax-advantaged spending accounts, namely, health savings accounts, medical savings accounts, health reimbursement arrangements, and medical and dependent care flexible spending accounts and telemedicine and wellness programs; Providing information and financial advice to patients in the fields of employee benefit plans, health insurance, health care benefit plans, pharmacy benefits plans, health care treatment options, telemedicine and wellness programs, tax-advantaged spending accounts, namely, health savings accounts, medical savings accounts, health reimbursement arrangements, and medical and dependent care flexible spending accounts; providing financial advice to others in the field of health care regarding medical treatment and procedure options, diagnostic service costs and options and pharmaceutical costs
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
036
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEALTH"